• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对被忽视的热带病进行流行情况调查的设计和分析的现代化。

Modernizing the design and analysis of prevalence surveys for neglected tropical diseases.

机构信息

CHICAS, Lancaster Medical School, Lancaster University, Lancaster, LA1 3YF, UK.

Task Force for Global Health, 325 Swanton Way, Decatur, 30030, GA, USA.

出版信息

Philos Trans R Soc Lond B Biol Sci. 2023 Oct 9;378(1887):20220276. doi: 10.1098/rstb.2022.0276. Epub 2023 Aug 21.

DOI:10.1098/rstb.2022.0276
PMID:37598704
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10440170/
Abstract

Current WHO guidelines set prevalence thresholds below which a neglected tropical disease can be considered to have been eliminated as a public health problem, and specify how surveys to assess whether elimination has been achieved should be designed and analysed, based on classical survey sampling methods. In this paper, we describe an alternative approach based on geospatial statistical modelling. We first show the gains in efficiency that can be obtained by exploiting any spatial correlation in the underlying prevalence. We then suggest that the current guidelines' implicit use of a significance testing argument is not appropriate; instead, we argue for a predictive inferential framework, leading to design criteria based on controlling the rates at which areas whose true prevalence lies above and below the elimination threshold are incorrectly classified. We describe how this approach naturally accommodates context-specific information in the form of georeferenced covariates that have been shown to be predictive of disease prevalence. Finally, we give a progress report of an ongoing collaboration with the Guyana Ministry of Health Neglected Tropical Disease programme on the design of an IDA (ivermectin, diethylcarbamazine and albendazole) Impact Survey of lymphatic filariasis to be conducted in Guyana in early 2023. This article is part of the theme issue 'Challenges and opportunities in the fight against neglected tropical diseases: a decade from the London Declaration on NTDs'.

摘要

当前的世界卫生组织指南设定了流行阈值,低于该阈值,可认为某种被忽视的热带病已不再构成公共卫生问题,还规定了如何根据经典的调查抽样方法来设计和分析评估是否已消除的调查。在本文中,我们描述了一种基于地理空间统计建模的替代方法。我们首先展示了通过利用潜在流行率中的任何空间相关性可以获得的效率增益。然后,我们提出当前指南中隐含的显著性检验论点并不适用;相反,我们主张采用预测推理框架,从而制定基于控制真实流行率高于和低于消除阈值的区域被错误分类的速率的设计标准。我们描述了这种方法如何自然地适应以地理参考协变量的形式呈现的特定于上下文的信息,这些协变量已被证明可预测疾病流行率。最后,我们报告了与圭亚那卫生部被忽视热带病规划正在进行的合作的进展情况,该合作涉及在圭亚那于 2023 年初进行伊维菌素、乙胺嗪和阿苯达唑(IDA)淋巴丝虫病影响调查的设计。本文是主题为“防治被忽视热带病的挑战和机遇:距离伦敦宣言发布十年”的一部分。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c37/10440170/d301760e3e4f/rstb20220276f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c37/10440170/ba2f096f75e3/rstb20220276f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c37/10440170/8eb4ae08c8de/rstb20220276f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c37/10440170/d301760e3e4f/rstb20220276f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c37/10440170/ba2f096f75e3/rstb20220276f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c37/10440170/8eb4ae08c8de/rstb20220276f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c37/10440170/d301760e3e4f/rstb20220276f03.jpg

相似文献

1
Modernizing the design and analysis of prevalence surveys for neglected tropical diseases.对被忽视的热带病进行流行情况调查的设计和分析的现代化。
Philos Trans R Soc Lond B Biol Sci. 2023 Oct 9;378(1887):20220276. doi: 10.1098/rstb.2022.0276. Epub 2023 Aug 21.
2
Introduction to the special issue: challenges and opportunities in the fight against neglected tropical diseases: a decade from the London Declaration on NTDs.特刊介绍:从伦敦消灭被忽视热带病宣言到现在的十年:防治被忽视热带病的挑战与机遇。
Philos Trans R Soc Lond B Biol Sci. 2023 Oct 9;378(1887):20220272. doi: 10.1098/rstb.2022.0272. Epub 2023 Aug 21.
3
The impact of ivermectin, diethylcarbamazine citrate, and albendazole mass drug administration on the prevalence of scabies and soil-transmitted helminths in school-aged children in three municipalities in Timor-Leste: a before-after assessment.伊维菌素、柠檬酸双羟萘酸噻嘧啶和阿苯达唑群体药物治疗对东帝汶三个直辖市学龄儿童疥疮和土壤传播性蠕虫感染率的影响:前后评估。
Lancet Glob Health. 2023 Jun;11(6):e924-e932. doi: 10.1016/S2214-109X(23)00134-1.
4
Lymphatic filariases and soil-transmitted helminthiases in Sri Lanka: the challenge of eliminating residual pockets of transmission.斯里兰卡的淋巴丝虫病和土壤传播性蠕虫病:消除剩余传播点的挑战。
Philos Trans R Soc Lond B Biol Sci. 2023 Oct 9;378(1887):20220280. doi: 10.1098/rstb.2022.0280. Epub 2023 Aug 21.
5
The safety of combined triple drug therapy with ivermectin, diethylcarbamazine and albendazole in the neglected tropical diseases co-endemic setting of Fiji: A cluster randomised trial.在斐济被忽视热带病流行地区联合使用伊维菌素、乙胺嗪和阿苯达唑三联药物治疗的安全性:一项集群随机试验。
PLoS Negl Trop Dis. 2020 Mar 16;14(3):e0008106. doi: 10.1371/journal.pntd.0008106. eCollection 2020 Mar.
6
How Thailand eliminated lymphatic filariasis as a public health problem.泰国如何消除淋巴丝虫病这一公共卫生问题。
Infect Dis Poverty. 2019 May 27;8(1):38. doi: 10.1186/s40249-019-0549-1.
7
An open label, block randomized, community study of the safety and efficacy of co-administered ivermectin, diethylcarbamazine plus albendazole vs. diethylcarbamazine plus albendazole for lymphatic filariasis in India.一项在印度开展的伊维菌素、乙胺嗪加阿苯达唑联合用药与乙胺嗪加阿苯达唑单药治疗淋巴丝虫病的开放性标签、块随机、社区研究,评估联合用药的安全性和疗效。
PLoS Negl Trop Dis. 2021 Feb 16;15(2):e0009069. doi: 10.1371/journal.pntd.0009069. eCollection 2021 Feb.
8
An open label, randomized clinical trial to compare the tolerability and efficacy of ivermectin plus diethylcarbamazine and albendazole vs. diethylcarbamazine plus albendazole for treatment of brugian filariasis in Indonesia.一项开放性标签、随机临床试验,旨在比较伊维菌素加乙胺嗪和阿苯达唑与乙胺嗪加阿苯达唑治疗印度尼西亚班氏丝虫病的耐受性和疗效。
PLoS Negl Trop Dis. 2021 Mar 29;15(3):e0009294. doi: 10.1371/journal.pntd.0009294. eCollection 2021 Mar.
9
Albendazole alone or in combination with microfilaricidal drugs for lymphatic filariasis.阿苯达唑单独使用或与抗微丝蚴药物联合用于治疗淋巴丝虫病。
Cochrane Database Syst Rev. 2019 Jan 8;1(1):CD003753. doi: 10.1002/14651858.CD003753.pub4.
10
A positive consequence of the COVID-19 pandemic: how the counterfactual experience of school closures is accelerating a multisectoral response to the treatment of neglected tropical diseases.COVID-19 大流行带来的一个积极后果:学校关闭的反事实经验如何加速多部门对被忽视热带病治疗的应对。
Philos Trans R Soc Lond B Biol Sci. 2023 Oct 9;378(1887):20220282. doi: 10.1098/rstb.2022.0282. Epub 2023 Aug 21.

引用本文的文献

1
Introduction to the special issue: challenges and opportunities in the fight against neglected tropical diseases: a decade from the London Declaration on NTDs.特刊介绍:从伦敦消灭被忽视热带病宣言到现在的十年:防治被忽视热带病的挑战与机遇。
Philos Trans R Soc Lond B Biol Sci. 2023 Oct 9;378(1887):20220272. doi: 10.1098/rstb.2022.0272. Epub 2023 Aug 21.

本文引用的文献

1
Statistical methods for linking geostatistical maps and transmission models: Application to lymphatic filariasis in East Africa.统计方法将地质统计学地图和传播模型相连接:在东非淋巴丝虫病中的应用。
Spat Spatiotemporal Epidemiol. 2022 Jun;41:100391. doi: 10.1016/j.sste.2020.100391. Epub 2020 Nov 21.
2
Model-Based Geostatistical Methods Enable Efficient Design and Analysis of Prevalence Surveys for Soil-Transmitted Helminth Infection and Other Neglected Tropical Diseases.基于模型的地质统计学方法可提高土壤传播性蠕虫感染和其他被忽视热带病流行调查的设计和分析效率。
Clin Infect Dis. 2021 Jun 14;72(Suppl 3):S172-S179. doi: 10.1093/cid/ciab192.
3
Rethinking neglected tropical disease prevalence survey design and analysis: a geospatial paradigm.
重新思考被忽视热带病流行情况调查设计和分析:一个地理空间范例。
Trans R Soc Trop Med Hyg. 2021 Mar 6;115(3):208-210. doi: 10.1093/trstmh/trab020.
4
Design and Analysis of Elimination Surveys for Neglected Tropical Diseases.消除被忽视热带病的抽样调查设计与分析。
J Infect Dis. 2020 Jun 11;221(Suppl 5):S554-S560. doi: 10.1093/infdis/jiz554.
5
Spatial modelling and the prediction of Loa loa risk: decision making under uncertainty.罗阿丝虫病风险的空间建模与预测:不确定性下的决策制定
Ann Trop Med Parasitol. 2007 Sep;101(6):499-509. doi: 10.1179/136485913X13789813917463.
6
Ecological bias, confounding, and effect modification.生态偏倚、混杂因素及效应修饰。
Int J Epidemiol. 1989 Mar;18(1):269-74. doi: 10.1093/ije/18.1.269.